TYVASO
- Product NDC
- 66302-206
- 11-digit product format
- 663020206
- Labeler code
- 66302
- Product ID
- 66302-206_78a0b514-481a-4ea9-8ec6-8b60acdf2158
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- treprostinil
- Dosage form
- INHALANT
- Route
- ORAL
- Labeler
- United Therapeutics Corporation
- Application
- NDA022387
- Marketing category
- NDA
- Marketing start
- 2009-08-14
- Substance
- TREPROSTINIL
- Active strength
- 1.74 mg/2.9mL
- Pharmacologic classes
- Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TYVASO
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TREPROSTINIL | 1.74 mg/2.9mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | RUM6K67ESG |
| Rxcui | 857795, 857799 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d31d7280-9cbd-4e8c-ad8c-a830d9d6c4bf | Product name | 1 | 20260309 |
| 3a764347-294a-401b-979f-44c1c6bb101a | Product name | 1 | 20230126 |
| 5e14eefc-ad08-9fbf-a28c-67c518b16369 | Product name | 5 | 20210727 |
| 799cd7a2-692a-4730-993b-8b702e954a56 | Product name | 1 | 20200407 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66302-206-01 | TYVASO | 28 in 1 BOX | INHALANT | 28 | 32 | |
| 66302-206-01 | TYVASO | 1 in 1 KIT | INHALANT | 1 | 32 | |
| 66302-206-02 | TYVASO | 1 in 1 KIT | INHALANT | 1 | 32 | |
| 66302-206-02 | TYVASO | 28 in 1 BOX | INHALANT | 28 | 32 | |
| 66302-206-03 | TYVASO | 2.9 mL in 1 AMPULE | INHALANT | 2.9 | 32 | |
| 66302-206-03 | TYVASO | 4 in 1 BOX | INHALANT | 4 | 32 | |
| 66302-206-04 | TYVASO | 1 in 1 KIT | INHALANT | 1 | 32 | |
| 66302-206-04 | TYVASO | 4 in 1 BOX | INHALANT | 4 | 32 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66302-206-01 | ML - Milliliter | 66302-206 | 8f391d44-9e23-4ad5-90fd-a9cab9349c12 | 1 | 2012-07-24 |
| 66302-206-02 | ML - Milliliter | 66302-206 | 6bb1135b-c664-47d2-b643-47606754eb65 | 1 | 2012-07-24 |
| 66302-206-03 | ML - Milliliter | 66302-206 | 1c587a30-98b1-4853-8b5d-165a24df7295 | 1 | 2012-07-24 |
| 66302-206-04 | ML - Milliliter | 66302-206 | 947f7574-1019-4ba1-b561-d999d10d81bb | 1 | 2014-12-01 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| treprostinil | ACTIVE INGREDIENT | RUM6K67ESG | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| treprostinil | ACTIVE MOIETY | RUM6K67ESG | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | TYVASO (TREPROSTINIL) INHALANT [UNITED THERAPEUTICS CORP.] | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 857795 | treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution | PSN | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857799 | TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution | PSN | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857799 | treprostinil 0.6 MG/ML Inhalation Solution [Tyvaso] | SBD | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857795 | treprostinil 0.6 MG/ML Inhalation Solution | SCD | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857795 | treprostinil 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution | SY | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857799 | Tyvaso 0.6 MG/ML Inhalation Solution | SY | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
| 857799 | Tyvaso 1.74 MG per 2.9 ML Inhalation Solution | SY | cbc31ab1-a80f-4b50-a3b1-39910b0fb609 | 32 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 66302-206-01 | 66302020601 | 1 BOX in 1 KIT (66302-206-01) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE | 1 box | 2009-08-14 | 0000-00-00 | No | No | Current |
| 66302-206-02 | 66302020602 | 1 BOX in 1 KIT (66302-206-02) / 28 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE | 1 box | 2009-08-14 | 0000-00-00 | No | No | Current |
| 66302-206-03 | 66302020603 | 4 AMPULE in 1 BOX (66302-206-03) / 2.9 mL in 1 AMPULE | 4 ampule | 2009-08-14 | 0000-00-00 | No | No | Current |
| 66302-206-04 | 66302020604 | 1 BOX in 1 KIT (66302-206-04) / 4 AMPULE in 1 BOX / 2.9 mL in 1 AMPULE | 1 box | 2009-08-14 | 0000-00-00 | No | No | Current |